These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator. Berger JP; Petro AE; Macnaul KL; Kelly LJ; Zhang BB; Richards K; Elbrecht A; Johnson BA; Zhou G; Doebber TW; Biswas C; Parikh M; Sharma N; Tanen MR; Thompson GM; Ventre J; Adams AD; Mosley R; Surwit RS; Moller DE Mol Endocrinol; 2003 Apr; 17(4):662-76. PubMed ID: 12554792 [TBL] [Abstract][Full Text] [Related]
10. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Kallen CB; Lazar MA Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5793-6. PubMed ID: 8650171 [TBL] [Abstract][Full Text] [Related]
11. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation. Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924 [TBL] [Abstract][Full Text] [Related]
12. Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis. Wang M; Tafuri S J Cell Biochem; 2003 May; 89(1):38-47. PubMed ID: 12682906 [TBL] [Abstract][Full Text] [Related]
13. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes. Camp HS; Chaudhry A; Leff T Endocrinology; 2001 Jul; 142(7):3207-13. PubMed ID: 11416043 [TBL] [Abstract][Full Text] [Related]
14. Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro. Su JL; Winegar DA; Wisely GB; Sigel CS; Hull-Ryde EA Hybridoma; 1999 Jun; 18(3):273-80. PubMed ID: 10475242 [TBL] [Abstract][Full Text] [Related]
15. Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. Adams M; Montague CT; Prins JB; Holder JC; Smith SA; Sanders L; Digby JE; Sewter CP; Lazar MA; Chatterjee VK; O'Rahilly S J Clin Invest; 1997 Dec; 100(12):3149-53. PubMed ID: 9399962 [TBL] [Abstract][Full Text] [Related]
16. Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608. Wiesenberg I; Chiesi M; Missbach M; Spanka C; Pignat W; Carlberg C Mol Pharmacol; 1998 Jun; 53(6):1131-8. PubMed ID: 9614218 [TBL] [Abstract][Full Text] [Related]
17. The transcription factor Fos-related antigen 1 is induced by thiazolidinediones during differentiation of 3T3-L1 cells. Albrektsen T; Fleckner J Mol Pharmacol; 2001 Mar; 59(3):567-75. PubMed ID: 11179452 [TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect. Armoni M; Kritz N; Harel C; Bar-Yoseph F; Chen H; Quon MJ; Karnieli E J Biol Chem; 2003 Aug; 278(33):30614-23. PubMed ID: 12777391 [TBL] [Abstract][Full Text] [Related]